HbA1c to Blood Sugar Converter — Estimated Average Glucose

What Blood Sugar Conversion Does

Blood glucose concentration can be reported in two different units depending on your location: milligrams per deciliter (mg/dL), which is standard in the United States, and millimoles per liter (mmol/L), which is used in most other countries including the UK, Canada, Australia, and Europe. This converter allows instant, accurate conversion between both units so that you can interpret lab results, glucose meter readings, or medical advice regardless of which unit is used.

The conversion is based on the molar mass of glucose — the weight of one mole of glucose molecules. Glucose has a molecular formula of C₆H₁₂O₆, giving it a molar mass of 180.182 g/mol. This fundamental chemical constant serves as the bridge between the mass-based unit (mg/dL) and the molar-based unit (mmol/L).

Conversion Formulas

Worked Example

Suppose your fasting blood glucose reading is 126 mg/dL. To convert to mmol/L: 126 ÷ 18.0182 = 7.0 mmol/L. This is the diagnostic threshold for diabetes according to the American Diabetes Association. Conversely, if a lab report shows a value of 5.6 mmol/L, convert to mg/dL: 5.6 × 18.0182 = 100.9 mg/dL ≈ 101 mg/dL. This is the upper end of the normal fasting range.

FAQ-Style Explanations

Why is the conversion factor 18.0182 and not exactly 18? The exact factor is derived from the molar mass of glucose (180.182 g/mol) divided by 10 (since 1 dL = 0.1 L). Many people use 18 as a quick approximation, but for clinical accuracy, especially at higher glucose levels, the full factor of 18.0182 should be used.

Which unit should I use? Use whichever unit your local healthcare system uses. In the US, all labs and glucose meters report in mg/dL. In most other countries, mmol/L is standard. The converter helps you move between the two seamlessly if you travel, consult international specialists, or read research from other countries.

Can I use this conversion for HbA1c? No. HbA1c (glycated hemoglobin) is a different measurement that represents average blood sugar over 2–3 months. It is reported as a percentage or in mmol/mol and requires a different conversion formula.

Known Limitations

• This converter provides accurate unit conversion but does not interpret your blood sugar levels — always consult a healthcare provider for medical interpretation.
• The conversion factor is based on the molecular weight of glucose in its standard form. Extremely rare laboratory variations in measurement techniques may introduce minor discrepancies at the thousandths place.
• Some glucose meters report in whole numbers only (e.g., 100 mg/dL rather than 100.0 mg/dL), which can introduce rounding differences of ±1 mg/dL or ±0.1 mmol/L.
• The reference ranges shown are general guidelines. Individual targets may vary based on age, diabetes type, pregnancy status, and other medical factors.

Reference Ranges

The HbA1c to eAG Formula

The relationship between HbA1c and estimated average glucose (eAG) was established by the Adventist Diagnostic Medical Center (formerly A1C to Average Glucose, or ADAG) study, which enrolled 508 participants with and without diabetes and collected paired measurements of HbA1c and frequent blood glucose samples over a 3-month period. The resulting regression equation, now widely adopted by the American Diabetes Association, is: eAG (mg/dL) = 28.7 × A1C − 46.7. To convert eAG from mg/dL to mmol/L, divide by 18.018. For example, an HbA1c of 7.0 percent converts to an eAG of 154 mg/dL (28.7 × 7.0 − 46.7 = 154.2) or 8.6 mmol/L (154 ÷ 18.018 = 8.5). This conversion allows patients to understand their HbA1c result in the same units they see on their daily blood glucose meter readings, making the 3-month average more intuitive. It is important to note that eAG represents a statistical average and may not exactly match the simple average of an individual's daily readings, which can vary due to the non-linear relationship between glucose exposure and hemoglobin glycation.

HbA1c to eAG Conversion Table

The table below shows common HbA1c values alongside their corresponding eAG in both mg/dL and mmol/L. This table covers the full range from normal through poorly controlled diabetes and includes clinical context for each level. Use this table for quick reference, or the converter on this page for intermediate values. The clinical significance column references the ADA classification for non-pregnant adults.

Understanding HbA1c and Its Time Window

HbA1c reflects the average glucose exposure over the preceding 2 to 3 months, weighted more heavily toward the most recent weeks because red blood cells that are newer have had less time for glucose to attach to their hemoglobin. Specifically, the most recent 30 days contribute approximately 50 to 70 percent of the HbA1c value, while the preceding 30 to 60 days contribute the remainder. This means that a recent improvement in blood sugar control will lower HbA1c within 4 to 6 weeks, while a recent deterioration will raise it within a similar timeframe. HbA1c is measured by laboratories using standardised assays that have been calibrated against the Diabetes Control and Complications Trial (DCCT) reference method, ensuring consistency across laboratories worldwide. For most individuals, an HbA1c change of 0.5 percent or less is within the normal range of laboratory variation and should not be read as a clinically meaningful change.

HbA1c vs Daily Glucose Readings

HbA1c and daily blood glucose readings measure related but distinct things. Daily readings capture point-in-time values that can fluctuate significantly with meals, exercise, stress, illness, and medications. HbA1c smooths out this day-to-day variability into a single average number, which is why it is the standard metric for long-term diabetes management and treatment adjustment. However, two individuals with the same HbA1c can have very different glucose patterns: one may have a stable glucose around their average, while another may experience wide swings between highs and lows that average to the same value. This is why the ADA now recommends that individuals on insulin or continuous glucose monitoring also track time in range (TIR) — the percentage of the day that glucose stays between 70 and 180 mg/dL (3.9 to 10.0 mmol/L). A target TIR of above 70 percent is associated with similar complications reduction as HbA1c below 7.0 percent, and TIR captures glucose variability that HbA1c alone cannot.

Limitations of HbA1c as an Average Glucose Measure

HbA1c is an excellent population-level measure of average glucose but has known limitations at the individual level. Conditions that alter red blood cell lifespan can skew results: hemolytic anemia, sickle cell disease, recent blood loss or transfusion, and treatment with drugs that suppress erythropoiesis all shorten red blood cell survival and artificially lower HbA1c. Conversely, iron-deficiency anemia, vitamin B12 deficiency, and hypothyroidism can prolong red blood cell survival and artificially raise HbA1c. Certain hemoglobin variants (hemoglobinopathies) common in individuals of African, Mediterranean, and Southeast Asian descent can interfere with some HbA1c assay methods, producing inaccurate results. For these individuals, alternative measures such as fructosamine (reflecting a 2 to 3 week average) or continuous glucose monitoring-derived time in range are more reliable. Additionally, the ADAG study from which the eAG formula was derived included participants from only one US geographic region, and there is some evidence that the HbA1c-to-glucose relationship may vary slightly by ethnicity, though the formula is used globally as a standard approximation.